The benefits of sacubitril-valsartan in patients with acute myocardial infarction: a systematic review and meta-analysis.

ESC heart failure(2021)

引用 13|浏览9
暂无评分
摘要
This meta-analysis suggests that early administration of sacubitril-valsartan may be superior to conventional ACEI/ARB to decrease the risk of hospitalization for HF, improve the cardiac function, and reverse the LV remodelling in patients following AMI.
更多
查看译文
关键词
Acute myocardial infarction,Angiotensin receptor blockers,Angiotensin-converting enzyme inhibitors,Heart failure,Meta-analysis,Sacubitril-valsartan
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要